r NBIX Stock Quote - Neurocrine Biosciences, Inc. Stock Price Today
TONIGHT! Join in as Kyle Dennis, 27 year-old,
self-made millionaire, reveals his newest trading strategy.
Days
Hours
Minutes
Seconds

Neurocrine Biosciences, Inc.
(NASDAQ : NBIX)

( )
NBIX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.00%79.541.2%$617.34m
AMGNAmgen Inc.
0.00%177.961.2%$579.57m
GILDGilead Sciences, Inc.
0.00%67.530.9%$547.73m
BIIBBiogen Inc.
0.00%284.411.2%$489.40m
REGNRegeneron Pharmaceuticals, Inc.
0.00%294.612.6%$305.85m
ILMNIllumina, Inc.
0.00%270.833.5%$228.12m
VRTXVertex Pharmaceuticals Incorporated
0.00%156.971.9%$223.27m
ALXNAlexion Pharmaceuticals, Inc.
0.00%117.142.0%$216.01m
AAgilent Technologies, Inc.
0.00%64.131.5%$205.67m
NKTRNektar Therapeutics
0.00%80.586.0%$188.74m
INCYIncyte Corporation
0.00%66.672.5%$152.87m
SRPTSarepta Therapeutics, Inc.
0.00%89.9916.6%$124.68m
BMRNBioMarin Pharmaceutical Inc.
0.00%88.284.4%$120.50m
EXASExact Sciences Corporation
0.00%52.8525.5%$108.34m
BLUEBluebird Bio, Inc.
0.00%187.0015.7%$96.24m

Company Profile

Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.